EAM
RGLS

Exome Asset Management’s Regulus Therapeutics RGLS Stock Holding History

Exome Asset Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-402,504
Closed -$1.16M – 69
2024
Q1 		$1.16M Buy
402,504
+224,100
+126% +$645K 0.99% 43
2023
Q4 		$228K Buy
+178,404
New +$228K 0.23% 51